|
[Related PubMed/MEDLINE]
Total Number of Papers: 695
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
A retrospective cohort study on predictors associated with skull base invasion of maxillary ameloblastomas. |
AEG-1, alpha-SMA, KPS, MA, SBI |
| 2 |
2022 |
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model. |
ccRCC, MHC, UNT |
| 3 |
2022 |
Carbonic anhydrase IX proteoglycan-like and intracellular domains mediate pulmonary microvascular endothelial cell repair and angiogenesis. |
ARDS, CA, IC, PG, PMVECs, TM |
| 4 |
2022 |
Carbonic anhydrase IX-targeted H-APBC nanosystem combined with phototherapy facilitates the efficacy of PI3K/mTOR inhibitor and resists HIF-1α-dependent tumor hypoxia adaptation. |
ABS, Ce6, HIF-1alpha, HPDA |
| 5 |
2022 |
Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation. |
CAs |
| 6 |
2022 |
Copper-based theranostic nanocatalysts for synergetic photothermal-chemodynamic therapy. |
CAI, CDT, MRI/PA, PTT |
| 7 |
2022 |
Design, synthesis and mechanistic study of new benzenesulfonamide derivatives as anticancer and antimicrobial agents via carbonic anhydrase IX inhibition. |
--- |
| 8 |
2022 |
Designing Lactate Dehydrogenase-Mimicking SnSe Nanosheets To Reprogram Tumor-Associated Macrophages for Potentiation of Photothermal Immunotherapy. |
LDH, SnSe NSs, TAM, TME |
| 9 |
2022 |
Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity. |
FGL1 |
| 10 |
2022 |
Early growth response 1 transcription factor is essential for the pathogenic properties of human endometriotic epithelial cells. |
Egr-1 |
| 11 |
2022 |
Hypoxia Marker Carbonic Anhydrase IX Is Present in Abdominal Aortic Aneurysm Tissue and Plasma. |
AAA, HIF-1alpha, s-CA IX |
| 12 |
2022 |
Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer. |
DFS, IHC, OS, TNBC |
| 13 |
2022 |
Intracellular pH-mediated induction of apoptosis in HeLa cells by a sulfonamide carbonic anhydrase inhibitor. |
--- |
| 14 |
2022 |
Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation. |
--- |
| 15 |
2022 |
New Developments in Carbonic Anhydrase IX-Targeted Fluorescence and Nuclear Imaging Agents. |
NIRF, PET, SPECT |
| 16 |
2022 |
Novel VHH-Based Tracers with Variable Plasma Half-Lives for Imaging of CAIX-Expressing Hypoxic Tumor Cells. |
--- |
| 17 |
2022 |
Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma. |
CAR-T, ECM |
| 18 |
2022 |
Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas. |
IHC, OTS |
| 19 |
2022 |
Understanding metabolic alterations and heterogeneity in cancer progression through validated immunodetection of key molecular components: a case of carbonic anhydrase IX. |
--- |
| 20 |
2021 |
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers. |
18F-FAZA, FTV, HGG |
| 21 |
2021 |
A Carbonic Anhydrase IX (CAIX)-Anchored Rhenium(I) Photosensitizer Evokes Pyroptosis for Enhanced Anti-Tumor Immunity. |
DCs, GSDMD, PDT |
| 22 |
2021 |
A NIR fluorescent smart probe for imaging tumor hypoxia. |
GBM, NTR |
| 23 |
2021 |
Affinity Selections of DNA-Encoded Chemical Libraries on Carbonic Anhydrase IX-Expressing Tumor Cells Reveal a Dependence on Ligand Valence. |
qPCR |
| 24 |
2021 |
Betulin Sulfonamides as Carbonic Anhydrase Inhibitors and Anticancer Agents in Breast Cancer Cells. |
BA, TNBC |
| 25 |
2021 |
Carbonic anhydrase IX and hypoxia-inducible factor 1 attenuate cardiac dysfunction after myocardial infarction. |
MI |
| 26 |
2021 |
Carbonic Anhydrase IX and Survivin in Colorectal Adenocarcinoma Cells: Slovakian Population Study. |
--- |
| 27 |
2021 |
Carbonic Anhydrase IX Promotes Human Cervical Cancer Cell Motility by Regulating PFKFB4 Expression. |
EMT, ERKs |
| 28 |
2021 |
Carbonic anhydrase IX: a regulator of pH and participant in carcinogenesis. |
ccRCC |
| 29 |
2021 |
Carbonic-anhydrase IX expression is increased in thyroid cancer tissue and represents a potential therapeutic target to eradicate thyroid tumor-initiating cells. |
TC, TICs |
| 30 |
2021 |
Chromophobe renal cell carcinoma-like thyroid carcinoma: possible misdiagnosis as metastatic renal cell carcinoma. |
ChRCC, CRETHCA, PAX8, TTF-1 |
| 31 |
2021 |
Contemporary update of SPECT tracers and novelties in radioguided surgery: a perspective based on urology. |
PSMA |
| 32 |
2021 |
Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck. |
F-MISO, FDG, GLUT-1, HIF-1alpha, HNSCC, HTV, IHC, PET/CT |
| 33 |
2021 |
Evaluation of 18F-EF5 for detection of hypoxia in localized adenocarcinoma of the prostate. |
GLUT1, OPN, PET |
| 34 |
2021 |
Expression of Myoglobin in Normal and Cancer Brain Tissues: Correlation With Hypoxia Markers. |
GBM, LDHA, Mb |
| 35 |
2021 |
Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis. |
ccRCC, IHC, MLPA, RCC |
| 36 |
2021 |
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors. |
--- |
| 37 |
2021 |
Granulocyte Colony Stimulating Factor Expression in Breast Cancer and Its Association with Carbonic Anhydrase IX and Immune Checkpoints. |
G-CSF |
| 38 |
2021 |
Histological Variants of Urothelial Carcinoma Predict No Response to Neoadjuvant Chemotherapy. |
MIBC, NAC |
| 39 |
2021 |
Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models. |
HNSCC |
| 40 |
2021 |
Immunohistochemistry-based hypoxia-immune prognostic classifier for head-and-neck cancer patients undergoing chemoradiation - Post-hoc analysis from a prospective imaging trial. |
HNSCC, LRC, TILs |
| 41 |
2021 |
Influence of Paclitaxel and Doxorubicin Therapy of ssIII-Tubulin, Carbonic Anhydrase IX, and Survivin in Chemically Induced Breast Cancer in Female Rat. |
CIS, DOX, IC, PTX |
| 42 |
2021 |
Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells. |
MMP, ROS |
| 43 |
2021 |
Inhibition of Carbonic Anhydrase IX Suppresses Breast Cancer Cell Motility at the Single-Cell Level. |
EGF |
| 44 |
2021 |
Inhibition of Carbonic Anhydrase Using SLC-149: Support for a Noncatalytic Function of CAIX in Breast Cancer. |
--- |
| 45 |
2021 |
Inhibitors of CA IX Enzyme Based on Polyhedral Boron Compounds. |
BNCT, SAR |
| 46 |
2021 |
Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity. |
BSA, DPBF, PACT, ROS, SAC |
| 47 |
2021 |
Lenvatinib enhances T cell immunity and the efficacy of adoptive chimeric antigen receptor-modified T cells by decreasing myeloid-derived suppressor cells in cancer. |
--- |
| 48 |
2021 |
Mimicking the Biology of Engineered Protein and mRNA Nanoparticle Delivery Using a Versatile Microfluidic Platform. |
--- |
| 49 |
2021 |
Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties. |
ALB, IS |
| 50 |
2021 |
Modulation of Tumor Microenvironment to Enhance Radiotherapy Efficacy in Esophageal Squamous Cell Carcinoma by Inhibiting Carbonic Anhydrase IX. |
ESCC |
| 51 |
2021 |
Overlapping Immunohistochemical Features of Adenocarcinoma of the Nonpigmented Ciliary Body Epithelium and Renal Cell Carcinoma. |
NPCE, RCC Ma |
| 52 |
2021 |
Primary prostate cancer synchronous with renal cell carcinoma: clinical experience and literature review. |
CD10, CT, EMA, Ki-67 LI, MRI, PAX8, PRAD, PSA, RCC |
| 53 |
2021 |
Prognostic Significance of Membranous Carbonic Anhydrase IX Expression in Patients with Nonmetastatic Clear Cell Renal Cell Carcinoma of Different Tumor Stages. |
ccRCC, CSS |
| 54 |
2021 |
Regulation of Tumor Metabolism and Extracellular Acidosis by the TIMP-10-CD63 Axis in Breast Carcinoma. |
TIMP-1 |
| 55 |
2021 |
Renal dysfunction and podocyturia in pre-eclampsia may be explained by increased urinary VEGF. |
PlGF, sFlt-1, VEGF |
| 56 |
2021 |
Repression of protocadherin 17 is correlated with elevated angiogenesis and hypoxia markers in female patients with breast cancer. |
Ang-2, BCPs, PCDH17 |
| 57 |
2021 |
Role of CAIX Expression in Conventional Renal Cell Carcinomas as a Diagnostic Marker and its Prognostic Importance. |
RCC |
| 58 |
2021 |
Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas. |
PCCs |
| 59 |
2021 |
Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer. |
CECs, MBC, OS, PFS |
| 60 |
2021 |
Targeting Hypoxic Tumors with Hybrid Nanobullets for Oxygen-Independent Synergistic Photothermal and Thermodynamic Therapy. |
AZ, HA, PTT, ROS, TDT |
| 61 |
2021 |
The hypoxia-sensor carbonic anhydrase IX affects macrophage metabolism, but is not a suitable biomarker for human cardiovascular disease. |
CAIXko, CVD, sCAIX |
| 62 |
2021 |
The role of carbonic anhydrase IX in the progression of malignant tumors - a potential therapeutic target? |
HIF1 |
| 63 |
2021 |
Tissue Expression of Carbonic Anhydrase IX Correlates to More Aggressive Phenotype of Basal Cell Carcinoma. |
BCC |
| 64 |
2020 |
A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients. |
ccRCC |
| 65 |
2020 |
A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity. |
CSCs, TNBC, VM |
| 66 |
2020 |
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma. |
Ad, DCs, GM, RCC |
| 67 |
2020 |
Biophysical Characterization of Cancer-Related Carbonic Anhydrase IX. |
MALDI-TOF, PG |
| 68 |
2020 |
CA IX Stabilizes Intracellular pH to Maintain Metabolic Reprogramming and Proliferation in Hypoxia. |
LDHA |
| 69 |
2020 |
CAIX-Mediated Control of LIN28/let-7 Axis Contributes to Metabolic Adaptation of Breast Cancer Cells to Hypoxia. |
ALDH1, CSCs, PDH, PDK1 |
| 70 |
2020 |
CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors. |
--- |
| 71 |
2020 |
Carbonic anhydrase IX immunohistochemistry has potential to predict renal cell carcinoma outcomes: A systematic review and meta-analyses. |
CI, IHC, PRISMA, RCC, RR |
| 72 |
2020 |
Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management. |
--- |
| 73 |
2020 |
Clinical and Pre-Clinical Evidence of Carbonic Anhydrase IX in Pancreatic Cancer and Its High Expression in Pre-Cancerous Lesions. |
--- |
| 74 |
2020 |
Cobalt Bis(dicarbollide) Alkylsulfonamides: Potent and Highly Selective Inhibitors of Tumor Specific Carbonic Anhydrase IX. |
--- |
| 75 |
2020 |
Combined 3-O-acetylbetulin treatment and carbonic anhydrase IX inhibition results in additive effects on human breast cancer cells. |
3-AC, BA, CAI, OCT |
| 76 |
2020 |
Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX. |
FA |
| 77 |
2020 |
Development of a 68 Ga-labelled PET tracer for carbonic anhydrase IX-overexpressed tumors using the artificial sweetener saccharin. |
p.i, SAC |
| 78 |
2020 |
Direct Introduction of an Alkylsulfonamido Group on C-sites of Isomeric Dicarba-closo-dodecaboranes: The Influence of Stereochemistry on Inhibitory Activity against the Cancer-Associated Carbonic Anhydrase IX Isoenzyme. |
SI |
| 79 |
2020 |
Dynamic surveillance of tamoxifen-resistance in ER-positive breast cancer by CAIX-targeted ultrasound imaging. |
--- |
| 80 |
2020 |
Glycolysis, via NADH-dependent dimerisation of CtBPs, regulates hypoxia-induced expression of CAIX and stem-like breast cancer cell survival. |
CtBPs, HIF, SCLC |
| 81 |
2020 |
How and Why Are Cancers Acidic? Carbonic Anhydrase IX and the Homeostatic Control of Tumour Extracellular pH. |
--- |
| 82 |
2020 |
Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA). |
DIANA, IOCB |
| 83 |
2020 |
Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging. |
CEA, EAC, EMA, EpCAM, HER2, LNM, VEGFA |
| 84 |
2020 |
Impairment of carbonic anhydrase IX ectodomain cleavage reinforces tumorigenic and metastatic phenotype of cancer cells. |
--- |
| 85 |
2020 |
In Search of Advanced Tumor Diagnostics and Treatment: Achievements and Perspectives of Carbonic Anhydrase IX Targeted Delivery. |
--- |
| 86 |
2020 |
In vitro and in vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells. |
BNCT, CA-SF |
| 87 |
2020 |
Inhibition of Melanoma Cell Migration and Invasion Targeting the Hypoxic Tumor Associated CAXII. |
Hh, Smo |
| 88 |
2020 |
Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against Glioblastoma. |
CAR, PP2A |
| 89 |
2020 |
Interplay of Carbonic Anhydrase IX With Amino Acid and Acid/Base Transporters in the Hypoxic Tumor Microenvironment. |
BioID, TME |
| 90 |
2020 |
Metabolic reprogramming and angiogenesis in primary cutaneous Merkel cell carcinoma: expression of hypoxia-inducible factor-1α and its central downstream factors. |
GLUT1, HIF-1alpha, MCC, MCPyV, MCT4, QS, VEGFR-3, VEGFR2 |
| 91 |
2020 |
Microsecond Simulation of the Proteoglycan-like Region of Carbonic Anhydrase IX and Design of Chemical Inhibitors Targeting pH Homeostasis in Cancer Cells. |
PG |
| 92 |
2020 |
Mitochondrial Dysfunction Inhibits Hypoxia-Induced HIF-1alpha Stabilization and Expression of Its Downstream Targets. |
HIF-1alpha, HIF-2alpha, mtDNA, OXPHOS, PHD2, ROS, VEGF |
| 93 |
2020 |
Myoglobin variants are expressed in human glioblastoma cells‑hypoxia effect? |
GBM, GLUT1, LDHA, Mb, RT, VEGF |
| 94 |
2020 |
Papillary-cystic neoplasms of the middle ear are distinct from endolymphatic sac tumours. |
APTs, CK, ELSTs, PAX8 |
| 95 |
2020 |
PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide. |
PET |
| 96 |
2020 |
Pharmacological Inhibition of CA-IX Impairs Tumor Cell Proliferation, Migration and Invasiveness. |
MMP-2 |
| 97 |
2020 |
PIMT Binding to C-Terminal Ala459 of CAIX Is Involved in Inside-Out Signaling Necessary for Its Catalytic Activity. |
PIMT |
| 98 |
2020 |
Prognostic value of CAIX expression in oral squamous cell carcinoma: a systematic review and meta-analysis. |
DFS, DSS, HR, LC, OS, OSCC |
| 99 |
2020 |
Sortase-Mediated Site-Specific Modification of Interleukin-2 for the Generation of a Tumor-Targeting Acetazolamide-Cytokine Conjugate. |
--- |
| 100 |
2020 |
Sulfonamido carboranes as highly selective inhibitors of cancer-specific carbonic anhydrase IX. |
--- |
|
A Search Service for Abbreviation / Long Form
